Cell-Delivery Route for Myoblast Transplantation in Heart Failure
Author Information
Author(s): Fukushima Satsuki, Coppen Steven R., Lee Joon, Yamahara Kenichi, Felkin Leanne E., Terracciano Cesare M. N., Barton Paul J. R., Yacoub Magdi H., Suzuki Ken
Primary Institution: Harefield Heart Science Centre, National Heart & Lung Institute, Imperial College London
Hypothesis
The use of a retrograde intracoronary route for skeletal myoblast delivery might improve therapeutic effects and reduce arrhythmogenicity.
Conclusion
Retrograde intracoronary injection of skeletal myoblasts provided significant therapeutic benefits with reduced early-phase arrhythmogenicity in treating ischemic cardiomyopathy.
Supporting Evidence
- Both injection routes improved cardiac performance and physical activity.
- Retrograde injection resulted in less myocardial damage compared to intramyocardial injection.
- Arrhythmias were more frequent after intramyocardial injection than after retrograde injection.
Takeaway
Injecting special heart cells through a different route can help the heart heal better and cause fewer problems than the usual method.
Methodology
Female wild-type rats underwent coronary artery ligation and were injected with skeletal myoblasts via intramyocardial or retrograde intracoronary routes, followed by assessments of cardiac function and arrhythmia monitoring.
Potential Biases
Potential bias due to the use of a single animal model and the lack of long-term follow-up.
Limitations
The study was conducted in a rat model, which may not fully replicate human responses.
Participant Demographics
Female wild-type Sprague-Dawley rats, aged 150-250g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website